Salud

Futuro de la vacunación anticovid: dosis adicionales, mezcla de productos y lucha contra variantes

Aunque es difícil imaginar lo que sucederá a mediano y largo plazo, lo registrado hasta hoy permite visualizar un posible terreno donde la ciencia y la epidemiología busquen respuestas en común

(FILES) In this file photo taken on August 07, 2021 (FILES) In this file photo taken on August 7, 2021, a dose of the Johnson and Johnson Covid-19 vaccine is prepared at a mobile vaccination clinic at the Weingart East Los Angeles YMCA in Los Angeles, California. - Drug maker Johnson & Johnson asked the US Federal Drug Administration on October 5, 2021, to authorize booster shots of its Covid-19 vaccine for people over the age of 18. "Our clinical program has found that a booster of our Covid-19 vaccine increases levels of protection for those who have received our single-shot vaccine to 94 percent," said Mathai Mammen, global head of research and development at J&J. (Photo by Patrick T. FALLON / AFP)
(FILES) In this file photo taken on August 07, 2021 (FILES) In this file photo taken on August 7, 2021, a dose of the Johnson and Johnson Covid-19 vaccine is prepared at a mobile vaccination clinic at the Weingart East Los Angeles YMCA in Los Angeles, California. - Drug maker Johnson & Johnson asked the US Federal Drug Administration on October 5, 2021, to authorize booster shots of its Covid-19 vaccine for people over the age of 18. "Our clinical program has found that a booster of our Covid-19 vaccine increases levels of protection for those who have received our single-shot vaccine to 94 percent," said Mathai Mammen, global head of research and development at J&J. (Photo by Patrick T. FALLON / AFP) PATRICK T. FALLON
‌
‌

‌

‌
‌

‌

‌